Evidence map›Paper›PMID 41499724›Full record

ArticleNeurology(R) neuroimmunology & neuroinflammation2026

OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD.

Thivya Pakeerathan, James Davis, Amanda D Henderson, Elias S Sotirchos, Yana Said, Joachim Havla, Marius Ringelstein, Orhan Aktas, Margit Weise, Jonathan A Gernert and 33 more

Abstract readMulticenter Study
In one paragraph

Article in Neurology(R) neuroimmunology & neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors.

Thivya PakeerathanDepartment of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Germany.ORCID 0009-0000-4271-4763
James DavisDivision of Neuro-Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD.ORCID 0009-0001-2618-4894
Amanda D HendersonDivision of Neuro-Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD.ORCID 0000-0002-8676-4292
Elias S SotirchosDepartment of Neurology, John Hopkins University, Baltimore, MD.ORCID 0000-0002-8812-1637
Yana SaidDepartment of Neurology, John Hopkins University, Baltimore, MD.ORCID 0009-0004-4350-1910
Joachim HavlaInstitute of Clinical Neuroimmunology, LMU University Hospital, LMU Munich, Germany.ORCID 0000-0002-4386-1340
Marius RingelsteinDepartment of Neurology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Germany.ORCID 0000-0003-3618-8407
Orhan AktasDepartment of Neurology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Germany.ORCID 0000-0002-2020-9210
Margit WeiseDepartment of Neurology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Germany.
Jonathan A GernertInstitute of Clinical Neuroimmunology, LMU University Hospital, LMU Munich, Germany.ORCID 0000-0002-6655-5557
Barbara KornekDepartment of Neurology, Medical University of Vienna, Austria.ORCID 0000-0002-1851-6967
Gabriel BstehDepartment of Neurology, Medical University of Vienna, Austria.ORCID 0000-0002-0825-0851
Paulus S RommerDepartment of Neurology, Medical University of Vienna, Austria.ORCID 0000-0001-5209-6647
Nik KrajncDepartment of Neurology, Medical University of Vienna, Austria.ORCID 0000-0002-4146-5870
Anne-Katrin PröbstelDepartments of Biomedicine and of Clinical Research, University Hospital Basel and University of Basel, Switzerland.ORCID 0000-0002-7748-1872
Athina PapadopoulouDepartment of Neurology, University Hospital Basel and University of Basel, Switzerland.ORCID 0000-0002-0367-1008
Laila KulsvehagenDepartments of Biomedicine and of Clinical Research, University Hospital Basel and University of Basel, Switzerland.ORCID 0000-0001-5236-8323
Roxanne PretzschDepartments of Biomedicine and of Clinical Research, University Hospital Basel and University of Basel, Switzerland.ORCID 0009-0001-4129-1276
Kean SchoenholzerResearch Center of Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel and University of Basel, Switzerland.ORCID 0009-0004-7755-4447
Tanyatuth PadungkiatsagulDepartment of Ophthalmology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.ORCID 0000-0002-5840-6172
Heather E MossDepartments of Ophthalmology and Neurology and Neurological Sciences, Stanford University, CA.ORCID 0000-0003-4373-447X
Sylvia E Villarreal NavarroDepartments of Ophthalmology and Neurology and Neurological Sciences, Stanford University, CA.ORCID 0009-0002-1013-7417
Marina HerwerthDepartment of Neurology, University Hospital Zurich, Switzerland.ORCID 0000-0001-5125-4594
Madalina GraureDepartment of Neurology, University Hospital Zurich, Switzerland.ORCID 0009-0003-5249-4567
Veronika KanaDepartment of Neurology, University Hospital Zurich, Switzerland.ORCID 0000-0002-9362-3156
Hadas Stiebel-KalishNeuro-ophthalmology Division Department of Ophthalmology, Rabin Medical Center and, Laboratory of Eye Research, Felsenstein Medical Research Center, Tel Aviv University, Israel.ORCID 0000-0001-7715-6706
Rita ZlatkinNeuro-ophthalmology Division Department of Ophthalmology, Rabin Medical Center and, Laboratory of Eye Research, Felsenstein Medical Research Center, Tel Aviv University, Israel.
Anthony C ArnoldDepartment of Ophthalmology, UCLA Stein Eye Institute, Los Angeles, CA.ORCID 0000-0002-9015-4542
Laura BonelliDepartment of Ophthalmology, UCLA Stein Eye Institute, Los Angeles, CA.ORCID 0000-0001-8819-3756
Jan-Patrick StellmannAPHM, Hopital de la Timone, CEMEREM, Marseille, France.ORCID 0000-0003-2565-2833
Natacha StolowyDepartment of Ophthalmology, Centre Hospitalier Universitaire de La Timone, Marseille, France.ORCID 0000-0003-3662-3800
Carolin SchwakeDepartment of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Germany.ORCID 0000-0003-3669-7244
Christiane Schneider-GoldDepartment of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Germany.ORCID 0000-0002-9232-201X
Tania KümpfelInstitute of Clinical Neuroimmunology, LMU University Hospital, LMU Munich, Germany.ORCID 0000-0001-7509-5268
Philipp AlbrechtDepartment of Neurology, Medical Faculty, Heinrich-Heine-University Düsseldorf, Germany.ORCID 0000-0001-7987-658X
Natthapon RattanathamsakulDivision of Neurology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Thailand.ORCID 0000-0002-1698-0520
Sean J PittockDepartment of Neurology, Center for Multiple Sclerosis and Autoimmune Neurology, Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; and.ORCID 0000-0002-6140-5584
Eoin P FlanaganDepartment of Neurology, Center for Multiple Sclerosis and Autoimmune Neurology, Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; and.ORCID 0000-0002-6661-2910
Sara CartaNeurology Unit, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Italy.ORCID 0000-0001-5248-456X
Sara MariottoNeurology Unit, Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Italy.ORCID 0000-0002-7806-3103
Ralf GoldDepartment of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Germany.ORCID 0000-0002-7223-3052
John J ChenDepartment of Ophthalmology, Mayo Clinic, Rochester, MN.ORCID 0000-0003-3644-7528
Ilya AyzenbergDepartment of Neurology, St. Josef-Hospital, Ruhr-University Bochum, Germany.ORCID 0009-0007-9491-2180

Funding

Stanford Vision Research CoreP30EY026877 · NEI · STANFORD UNIVERSITY · PI Jeffrey L Goldberg · 2017 to 2026
$8.0M
NEI NIH HHS P30 EY026877
6 · The paper itself

Abstract

BACKGROUND AND

objectivesSevere optic neuritis (ON) is a common clinical manifestation in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) and neuromyelitis optica spectrum disorder (NMOSD). Given distinct prognoses and often the necessity of early plasma exchange in NMOSD, prompt differentiation is crucial. In this study, we investigated the utility of optical coherence tomography (OCT) in differentiating between first acute NMOSD-ON and MOGAD-associated optic neuritis (MOGAD-ON), as well as specific factors associated with disc edema.

methodsIn this retrospective multicenter study, 111 adult patients with MOGAD or aquaporin-4 antibody-positive NMOSD who experienced a first ON and underwent OCT within 2 weeks of symptom onset were included from 14 centers across 8 countries. Peripapillary retinal nerve fiber layer (pRNFL) thickness in µm was analyzed, including the average of both eyes in cases of bilateral manifestation.

resultsEighty-three patients with MOGAD (51 women; 124 ON eyes; bilateral ON 48.2%) and 28 with NMOSD (24 women; 36 ON eyes; bilateral ON 21.4%) were enrolled. A significant increase in pRNFL thickness (>2SD), suggestive of disc edema, was observed in 73.4% of MOGAD-ON eyes and 11.1% of NMOSD-ON eyes ( DISCUSSION: Acute-stage OCT contributes to the rapid and accurate differentiation between MOGAD-ON and NMOSD-ON prior to antibody confirmation, which can be critical for timely therapeutic decisions.

Indexed as

Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseNeuromyelitis OpticaOptic NeuritisTomography, Optical CoherenceAcute DiseaseAdultDiagnosis, DifferentialFemaleHumansMaleMiddle AgedRetrospective StudiesYoung Adult

Identifiers

PMID41499724
PMCPMC12794538

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.